SCHEMBL24225223

SCHEMBL24225223

COc1cc(OC)cc(N2Cc3cnc(Nc4ccccc4N)nc3N(C)C2O)c1

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ FGFR4 P22455 16/20 0.49
▸ FGFR1 P11362 5/20 0.44
▸ FGFR2 P21802 5/20 0.44
▸ FGFR3 P22607 5/20 0.44
▸ EGFR P00533 4/20 0.42
▸ PDGFRB P09619 2/20 0.42
▸ PDGFRA P16234 2/20 0.42
▸ KDR P35968 2/20 0.42
▸ FYN P06241 1/20 0.42
▸ MAPK1 P28482 1/20 0.42
▸ EPHB3 P54753 1/20 0.42
▸ AURKA O14965 1/20 0.40
▸ CCNA2 P20248 1/20 0.40
▸ CDK2 P24941 1/20 0.40
▸ PLK1 P53350 1/20 0.40
▸ CCNA1 P78396 1/20 0.40
▸ PLK3 Q9H4B4 1/20 0.40
▸ PLK2 Q9NYY3 1/20 0.40
▸ MAP4K1 Q92918 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16071435 0.79 FGFR4 (0.77) FGFR4FGFR1FGFR2FGFR3KDR
SCHEMBL19069263 0.77 FGFR4 (0.42) FGFR4FGFR1FGFR2FGFR3EGFR
SCHEMBL21860422 0.75 FGFR4 (0.49) FGFR4FGFR1FGFR2FGFR3
SCHEMBL24225216 0.73 FGFR4 (0.49) FGFR4FGFR1FGFR2FGFR3
SCHEMBL23653399 0.73 EGFR (0.57) FGFR4FGFR1FGFR2FGFR3EGFR
SCHEMBL23653276 0.72 EGFR (0.44) FGFR4FGFR1FGFR2FGFR3EGFR
SCHEMBL24224962 0.72 FGFR4 (0.56) FGFR4FGFR1FGFR2FGFR3
SCHEMBL21166367 0.72 FGFR4 (0.62) FGFR4FGFR1FGFR2FGFR3EGFR
SCHEMBL16071425 0.71 FGFR4 (0.69) FGFR4FGFR1FGFR2FGFR3EGFR
SCHEMBL28640666 0.70 FGFR4 (0.72) FGFR4FGFR1FGFR2FGFR3EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3943087-A1 HETEROARYL COMPOUNDS AND USES THEREOF Celgene CAR LLC (BM) 2022-01-26 — — EP disclosed
Send feedback